The only problem before was that it was very expensive to produce. The proof was soon forthcoming. The University recently signed a technology transfer agreement with Leader Gene Ltd, a Hong Kong biotechnology firm that will use the system to produce hEGF for commercial use. By making supplemental hEGF available in skin care products, we can promote skin cell regeneration and meet the market demand of a fast-growing segment of the population. Through the Industry Department, the government should continue to sponsor research that yields technology that can be transferred.
Companies can then step in to commercialize the technology.
We wish biological scientists would transfer more innovations like this to local industry.